Advertisement
Screener

GT BIOPHARMA, INC. (GTBP) Net Income (Loss) Attributable to Noncontrolling Interest

1.8 / 5 stars · 19/52 Roast Me

GT BIOPHARMA, INC. Net Income (Loss) Attributable to Noncontrolling Interest

GT BIOPHARMA, INC. (GTBP) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2019-05-15

  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2019-03-31 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2018-06-30 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2018-03-31 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2017-12-31 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for fiscal 2017 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for fiscal 2016 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for fiscal 2015 was $0.00.
  • GT BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for fiscal 2014 was -$16.00K.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 12 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed
2019-03-31$0.00
10-Q · filed 2019-05-15
2018-06-30$0.00
10-Q · filed 2018-08-14
$0.00
10-Q · filed 2018-08-14
$0.00
derived: sum of 3 quarters · filed 2019-05-15
$0.00
derived: sum of 4 quarters · filed 2019-05-15
2018-03-31$0.00
10-Q · filed 2019-05-15
$0.00
derived: sum of 2 quarters · filed 2019-05-15
$0.00
derived: sum of 3 quarters · filed 2019-05-15
$0.00
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$0.00
derived: sum of 2 quarters · filed 2018-03-01
$0.00
derived: sum of 3 quarters · filed 2018-08-14
$0.00
10-K · filed 2018-03-01
2017-09-30$0.00
10-Q · filed 2017-11-14
$0.00
derived: sum of 2 quarters · filed 2018-08-14
$0.00
10-Q · filed 2017-11-14
$0.00
derived: sum of 4 quarters · filed 2018-08-14
2017-06-30$0.00
10-Q · filed 2018-08-14
$0.00
10-Q · filed 2018-08-14
$0.00
derived: sum of 3 quarters · filed 2018-08-14
$0.00
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$0.00
10-Q · filed 2018-05-15
$0.00
derived: sum of 2 quarters · filed 2018-05-15
$0.00
derived: sum of 3 quarters · filed 2018-05-15
$0.00
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$0.00
derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01
$0.00
derived: sum of 2 quarters · filed 2018-03-01
$0.00
derived: sum of 3 quarters · filed 2018-03-01
$0.00
10-K · filed 2018-03-01
2016-09-30$0.00
10-Q/A · filed 2018-02-28
$0.00
derived: sum of 2 quarters · filed 2018-02-28
$0.00
10-Q/A · filed 2018-02-28
$0.00
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$0.00
10-Q/A · filed 2018-02-28
$0.00
10-Q/A · filed 2018-02-28
$0.00
derived: sum of 3 quarters · filed 2018-02-28
$0.00
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$0.00
10-Q/A · filed 2018-02-28
$0.00
derived: sum of 2 quarters · filed 2018-02-28
$0.00
derived: sum of 3 quarters · filed 2018-02-28
$0.00
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$0.00
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28
$0.00
derived: sum of 2 quarters · filed 2018-02-28
$0.00
derived: sum of 3 quarters · filed 2018-02-28
$0.00
10-K/A · filed 2018-02-28
2015-09-30$0.00
10-Q/A · filed 2018-02-28
$0.00
derived: sum of 2 quarters · filed 2018-02-28
$0.00
10-Q/A · filed 2018-02-28
-$19.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-06-30$0.00
10-Q/A · filed 2018-02-28
$0.00
10-Q/A · filed 2018-02-28
-$19.00K
derived: sum of 3 quarters · filed 2018-02-28
-$18.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-03-31$0.00
10-Q/A · filed 2018-02-28
-$19.00K
derived: sum of 2 quarters · filed 2018-02-28
-$18.00K
derived: sum of 3 quarters · filed 2018-02-28
-$19.00K
derived: sum of 4 quarters · filed 2018-02-28
2014-12-31-$19.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28
-$18.00K
derived: sum of 2 quarters · filed 2018-02-28
-$19.00K
derived: sum of 3 quarters · filed 2018-02-28
-$16.00K
10-K/A · filed 2018-02-28
2014-09-30$1.00K
10-Q · filed 2015-11-13
$0.00
derived: sum of 2 quarters · filed 2015-11-13
$3.00K
10-Q · filed 2015-11-13
-$11.00K
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30-$1.00K
10-Q · filed 2015-08-14
$1.00K
10-Q · filed 2015-01-08
$2.00K
10-Q · filed 2015-08-14
-$12.00K
derived: sum of 3 quarters · filed 2015-08-14
-$58.00K
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31$1.00K
10-Q · filed 2015-05-14
-$11.00K
derived: sum of 2 quarters · filed 2015-05-14
-$57.00K
derived: sum of 3 quarters · filed 2015-05-14
-$66.00K
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
-$58.00K
derived: sum of 2 quarters · filed 2015-03-31
-$67.00K
derived: sum of 3 quarters · filed 2015-03-31
-$63.00K
10-K · filed 2015-03-31
2013-09-30-$46.00K
10-Q · filed 2014-12-17
-$55.00K
derived: sum of 2 quarters · filed 2015-01-08
-$51.00K
10-Q · filed 2015-01-08
-$103.00K
derived: sum of 4 quarters · filed 2015-01-08
2013-06-30-$9.00K
10-Q · filed 2015-01-08
$5.00K
10-Q · filed 2015-01-08
-$57.00K
derived: sum of 3 quarters · filed 2015-01-08
-$72.00K
derived: sum of 4 quarters · filed 2015-01-08
2013-03-31$14.00K
10-Q · filed 2015-01-08
-$48.00K
derived: sum of 2 quarters · filed 2015-01-08
-$63.00K
derived: sum of 3 quarters · filed 2015-01-08
-$76.00K
derived: sum of 4 quarters · filed 2015-01-08
2012-12-31-$62.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08
-$77.00K
derived: sum of 2 quarters · filed 2015-01-08
-$90.00K
derived: sum of 3 quarters · filed 2015-01-08
-$90.00K
10-K · filed 2015-01-08
$90.00K
10-K · filed 2014-11-18
2012-09-30-$15.00K
10-Q · filed 2014-12-17
$15.00K
10-Q · filed 2012-11-21
-$28.00K
derived: sum of 2 quarters · filed 2014-12-17
-$28.00K
10-Q · filed 2014-12-17
$28.00K
10-Q · filed 2012-11-21
-$28.00K
derived: sum of 4 quarters · filed 2014-12-17
2012-06-30-$13.00K
10-Q · filed 2014-12-12
$13.00K
10-Q/A · filed 2012-09-13
-$13.00K
10-Q · filed 2014-12-12
$13.00K
10-Q/A · filed 2012-09-13
-$13.00K
derived: sum of 3 quarters · filed 2014-12-12
-$13.00K
derived: sum of 4 quarters · filed 2014-12-12
2012-03-31$0.00
10-Q · filed 2014-12-10
$0.00
derived: sum of 2 quarters · filed 2014-12-10
$0.00
derived: sum of 3 quarters · filed 2014-12-10
$0.00
derived: sum of 4 quarters · filed 2014-12-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18
$0.00
derived: sum of 2 quarters · filed 2014-11-18
$0.00
derived: sum of 3 quarters · filed 2014-11-18
$0.00
10-K · filed 2014-11-18
2011-09-30$0.00
10-Q · filed 2012-11-21
$0.00
derived: sum of 2 quarters · filed 2012-11-21
$0.00
10-Q · filed 2012-11-21
2011-06-30$0.00
10-Q/A · filed 2012-09-13
$0.00
10-Q/A · filed 2012-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88